twandafelipe0312
/
Over a period of 10 years, evaluate the safety and efficacy of alemtuzumab for CARE-MS II patients
Share Over a period of 10 years, evaluate the safety and efficacy of alemtuzumab for CARE-MS II patients
Export
RSS
Embed
Copy Code
Code
<iframe style="border: 0; width: 100%; height: 450px;" allowfullscreen frameborder="0" src="https://raindrop.io/twandafelipe0312/over-a-period-of-10-years-evaluate-the-safety-and-efficacy-of-alemtuzumab-for-care-ms-ii-patients-21600282/embed"></iframe>
Sort
Custom (curator specified)
Custom (curator specified)
By date (newest)
By date (oldest)
By name (A-Z)
By name (Z-A)
Filter
Theme
Automatic (light or dark depending on user preferences)
Automatic (light or dark depending on user preferences)
Light
Dark
Hide elements
Preview